MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery

The views and opinions of the media, healthcare professionals, patients and caregivers may not be accurately represented based on the Vivistim System’s FDA approved indication. For more information, please visit www.vivistim.com/safety.